DRKS00014630
Completed
Not Applicable
Prediction Of Pre eclampsia at Early Gestation - ProPeg-1
Institute for Prenatal Health0 sites444 target enrollmentJune 1, 2018
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- O14.9
- Sponsor
- Institute for Prenatal Health
- Enrollment
- 444
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •normal singleton pregnancy of women age 18 or older between 11\+0 and 13\+6 weeks of gestation
Exclusion Criteria
- •\- fetuses with morphological malformations or aneuploidies
- •\- necessity of drug treatment of hypertension, or rheumatic diseases
- •\- taking ASS at any time during the pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prediction of preeclampsia and adverse eventspreeclampsiatoxemia10026908NL-OMON48757eids Universitair Medisch Centrum400
Completed
Not Applicable
First-trimester Prediction of PreeclampsiaPreeclampsiaSevere PreeclampsiaFetal Growth RestrictionPreterm BirthNCT02189148CHU de Quebec-Universite Laval7,554
Completed
Phase 1
Treating early onset severe preeclampsia with pravastatin: an early phase clinical trialPreeclampsiaReproductive Health and Childbirth - Fetal medicine and complications of pregnancyReproductive Health and Childbirth - Antenatal careACTRN12613000268741The Mercy Hospital for Women12
Not yet recruiting
Not Applicable
Diagnosis of pre-eclampsia.pre-eclampsiaNL-OMON20514aboratory for Clinical Chemistry & HaematologyAtrium Medisch Centrum Parkstad20
Not yet recruiting
Phase 3
A Prospective PreecLampsia/Eclampsia Preventative Intervention – Metformin (APPLE PIE) studyPregnancy and ChildbirthPACTR202107604428217Stellenbosch University1,430